Metabolic design of combination therapy: use of enhanced fluorodeoxyglucose uptake caused by chemotherapy.

Haberkorn, U

Metabolic design of combination therapy: use of enhanced fluorodeoxyglucose uptake caused by chemotherapy. [electronic resource] - Journal of nuclear medicine : official publication, Society of Nuclear Medicine Nov 1992 - 1981-7 p. digital

Publication Type: Journal Article

0161-5505


Antineoplastic Agents--administration & dosage
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Breast Neoplasms--diagnostic imaging
Chromatography, High Pressure Liquid
Deoxyglucose--administration & dosage
Drug Screening Assays, Antitumor
Fluorodeoxyglucose F18
Humans
Phosphorylcholine--administration & dosage
Tomography, Emission-Computed
Tumor Cells, Cultured--diagnostic imaging